social impact

Proud to Support a Powerful Mission

We are thrilled to announce that Swamy Sriperumbudur a seasoned entrepreneur of PCG GLOBAL and Chief AI Officer of ExpediteInfoTech, Inc., is participating in the Triangle Light The Night Executive Challenge to raise funds for Blood Cancer United’s mission to find cancer cures!

The Executive Challenge is a fundraising competition among business and community leaders around the country. Each year, this group of passionate leaders comes together to raise life-saving funds for the Blood Cancer United mission to cure blood cancers and transform treatment and care for cancer patients.

Thank you Swamy, for joining us this year for the challenge and bringing LIGHT to the darkness of cancer!

Swamy's Light The Night Fundraiser

Join me in bringing light to the darkness of cancer by donating towards my fundraising efforts in support of Blood Cancer United’s Light The Night. By donating today, you can help children like Lennox.

At just eight months old, confusing symptoms left his parents concerned about their son’s health. By his first birthday, his appetite was gone, his skin was pale and his development began to regress. The light of his spirit was dimming. After months of painful tests, Lennox was diagnosed with Langerhans cell histiocytosis (LCH) – a rare blood cancer.  Before he even learned to walk, his new normal was weekly chemotherapy treatments, steroids and regular hospital visits.

Fortunately – thanks to a clinical drug trial and his enduring spirit – Lennox finished treatment in December and recently celebrated his third birthday – a milestone his parents feared they might never reach as a family.

Lennox’s experience is a reminder that every medical breakthrough brings hope and more time for blood cancer patients and their families. Your support of Light The Night, allows Blood Cancer United, formerly the Leukemia & Lymphoma Society, to fund treatments for patients who are suffering from all forms of blood cancers. We proudly support the science that makes FDA drug approvals possible, including 80% of the 153 new approvals since 2017.

Please donate today and help us shine a light for blood cancer patients and their families.

*As of September 2025, The Leukemia & Lymphoma Society is now Blood Cancer United

Scroll to Top